norcantharidin has been researched along with Multiple Myeloma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, S; Chen, G; Dong, S; Feng, Q; Gao, X; Hu, K; Jia, Q; Jia, X; Li, B; Lu, M; Shi, J; Song, D; Wang, G; Wang, Y; Wu, X; Xie, Y; Xu, L; Xu, Z; Zhang, B; Zhang, H; Zhou, J; Zhu, H; Zhu, W | 1 |
| Du, HF; Fang, J; Li, Y; Lyu, HY; Zhang, JQ | 1 |
| Du, HF; Lü, HY; Meng, JB; Meng, YF; Song, XN; Sun, LX; Yu, LJ; Zhang, JQ | 1 |
| Du, HF; Lv, HY; Meng, J; Meng, YF; Song, XN; Yu, LJ; Zhang, JQ | 1 |
4 other study(ies) available for norcantharidin and Multiple Myeloma
| Article | Year |
|---|---|
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
Topics: 14-3-3 Proteins; Animals; Apoptosis; ATPases Associated with Diverse Cellular Activities; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Docking Simulation; Multiple Myeloma; Signal Transduction | 2023 |
[Norcantharidin induce anti-myeloma effect on nude mouse xenografts through NF-κB signal pathway].
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Heterografts; Male; Mice; Mice, Inbred Strains; Mice, Nude; Multiple Myeloma; NF-kappa B; Signal Transduction | 2013 |
[Norcantharidin potentialize the chemosensitivity of adriamycin through the NF-κB/IκBα signaling pathway].
Topics: bcl-2-Associated X Protein; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Doxorubicin; Humans; I-kappa B Proteins; Inhibitor of Apoptosis Proteins; Multiple Myeloma; NF-KappaB Inhibitor alpha; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Survivin; Transcription Factor RelA; Vascular Endothelial Growth Factor A | 2011 |
Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Bridged Bicyclo Compounds, Heterocyclic; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Humans; I-kappa B Kinase; I-kappa B Proteins; Male; Mice; Mice, Nude; Multiple Myeloma; NF-kappa B; NF-KappaB Inhibitor alpha; Pyrazines; Signal Transduction; Xenograft Model Antitumor Assays | 2013 |